期刊文献+

肿瘤转移抑制基因KAI1/CD82及细胞分子CD44v6在人喉鳞癌中的表达及意义 被引量:3

Expression of KAI1 / CD82 and CD44v6 in human laryngeal squamous cell carcinoma and their clinical significance
下载PDF
导出
摘要 目的探讨肿瘤转移抑制基因KAI1/CD82和细胞分子CD44v6在人喉鳞状细胞癌(laryngeal squamous cell carcinoma,LSCC)中的表达及意义,并探讨二者之间的关系。方法采用免疫组化En Vision法检测64例LSCC和15例正常喉黏膜(normal laryngeal mucosa,NLM)组织中KAI1/CD82和CD44v6的表达。结果 LSCC组织中KAI1/CD82蛋白的阳性率(37.50%)显著低于NLM组织(86.67%)(P=0.031);LSCC组织中CD44v6蛋白的阳性率(75.00%)显著高于NLM组织(26.67%)(P=0.011)。KAI1/CD82表达与LSCC临床分期、分化程度及淋巴结转移相关(P<0.05),与预后无关(P>0.05);CD44v6表达与LSCC分化程度、淋巴结转移及预后相关(P<0.05),与临床分期无关(P>0.05);二者均与患者年龄、性别无关(P>0.05)。KAI1/CD82与CD44v6在LSCC组织中的表达呈负相关(rs=-0.504,P=0.036)。结论 KAI1/CD82与CD44v6在LSCC的发生、发展和侵袭转移中起着相互抑制的作用,检测KAI1/CD82及CD44v6蛋白表达对判断LSCC的生物学行为具有重要价值。 Purpose To study the expression of metastasis suppressor gene (KAI1/CD82) and cell adhesion molecules(CD44v6) in human laryngeal squamous cell carcinoma ( LSCC) and its clinical significance, and to investigate their relationship. Methods EnVi-sion immunohistochemistry was used to detect the expression of KAI1/CD82 and CD44v6 protein in 64 cases of LSCC tissues and 15 ca-ses of normal laryngeal mucosa ( NLM) tissues. Results The positive rate of KAI1/CD82 in LSCC tissues ( 37. 50%) was signifi-cantly lower than that of the NLM tissues(86. 67%) (P=0. 031), and the positive rate of CD44v6 in LSCC tissues(75. 00%) was significantly higher than that of the NLM tissues(26. 67%) (P=0. 011). The expression of KAI1/CD82 was associated with clinical stages, grade of tumor differentiation, neck lymph node metastasis ( P〈0. 05 ) while not related with age, sex and prognosis ( P〉0. 05). And CD44v6 with grade of tumor differentiation, neck lymph node metastasis and prognosis (P〈0. 05), but not with age, sex and clinical stages (P〉0. 05). In addition, KAI1/CD82 expression was negatively correlated with CD44v6 expression (rs = -0. 504, P=0. 036). Conclusion KAI1/CD82 and CD44v6 are mutually inhibited in the tumorigenesis, progress, invasion and metastasis, and detection of the expression of KAI1/CD82 and CD44v6 may be helpful for judging the biological behaviors of LSCC.
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2015年第10期1127-1130,共4页 Chinese Journal of Clinical and Experimental Pathology
基金 贵州省科技联合基金[黔科合LS字(2012)031号]
关键词 喉肿瘤 鳞状细胞癌 KAI1/CD82 CD44V6 免疫组织化学 laryngeal neoplasms squamous cell carcinoma KAI1/CD82 CIM4v6 immunohistochemistry
  • 相关文献

参考文献18

  • 1Lebel-Binay S, Lagaudriere C, Fradelizi D, Conjeaud H. CD82, member of the tetra-span-transmembrane protein family, is a cos- timulatory protein for T cell activation[ J]. J Immunol, 1995,155 (1):101 -10.
  • 2Winder T, Ning Y, Yang D, et al. Germline polymorphisms in genes involved in the CIM4 signaling pathway are associated with clinical outcome in localized gastric adenocarcinoma [ J]. Int J Cancer, 2011,129(5 ) :1096 - 104.
  • 3Schindl M, Bachtiary B, Dreier B, et al. Impact of human papil- lomavirous infection on the expression of the KAI1 metastasis sup- pressor protein in invasive cervical cancer[J]. Cancer Lett, 2001, 162(2) :261 -6.
  • 4Dong J T, Lamb P W, Rinker-Schaeffer C W, et al. KAI1, a me- tastasis suppressor gene for prostate cancer on human chromosome llpll,2[J]. Science, 1995,268(5212):884-6.
  • 5Geradts J, Maynard R, Birrer M J, et al. Frequent loss of KAI1 expression in squamous and lymphoid neoplasms. An immunohis- tochemical study of archival tissues[ Jl. Am J Pathol, 1999,154 (6) :1665 -71.
  • 6王博谦,彭诗东.喉鳞癌组织KAI1和COX-2表达及相关性研究[J].中华肿瘤防治杂志,2012,19(20):1535-1538. 被引量:1
  • 7隋颖,康健.肿瘤转移抑制基因KAI1/CD82在N_0期声门上型喉鳞状细胞癌颈淋巴结隐匿性转移中的表达及临床研究[J].转化医学杂志,2013,2(4):203-207. 被引量:2
  • 8张炳辉,冯佳朋,邢文缘,徐秀玉,李晓丹,王宇.喉鳞癌中KAI1/CD82、MRP1/CD9的表达及意义[J].实用肿瘤学杂志,2013,27(4):295-302. 被引量:1
  • 9Liu Y J, Yan P S, Li J, et al. Expression and significance of CD44s, CD44v6, and nm23 mRNA in human eancer[J]. World J Gastroenterol, 2005,11 (42) :6601 - 4.
  • 10Levy I, Ovadia B, Erez E, et al. Nosoeomial infections alter car- diac surgery in infants and children: incidence and risk factors [J]. JHospInfect, 2003,53(2):111-6.

二级参考文献86

共引文献23

同被引文献30

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部